Tong, Xiaomeng 童小幪
Please note that due to the planned shutdown of Webb-site.com,
the directors, officers and advisers of HK-listed companies will cease to be updated effective 2025-03-31. Appointments
and resignations effective on or before that date will be recorded, as will advisers recorded in annual reports
filed on or before that date. We intend to make a data dump available after processing the final filings.
Main board
Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
---|---|---|---|---|---|---|---|---|
1 | Boyu Capital Advisory Co. Limited | MDManaging Director | 2011-05 | |||||
2 | * | Brii Biosciences Limited | NEDNon-Executive Director | 2021-06-22 | ||||
3 | * | CStone Pharmaceuticals | NEDNon-Executive Director | 2018-02-28 | 2019-05-15 | 4.51% | ||
4 | * | Damai Entertainment Holdings Limited (BM) | INEDIndependent Non-Executive Director | 2014-06-27 | -39.89% | -4.42% | -8.80% | |
5 | Guangzhou Kingmed Diagnostics Group Co., Ltd. | DirDirector | 2015-06 | |||||
6 | * | WuXi AppTec Co., Ltd. | NEDNon-Executive Director | 2017-03-01 | 365.71% | 25.40% | 20.99% | |
Average | 10.49% | 6.09% |
SFC roles
Organisation | Position | From | Until | ||
---|---|---|---|---|---|
1 | Providence Equity Asia Limited | RepRepresentative | 2011-02-09 | 2011-04-30 |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy